New study could let new moms get diabetes test before leaving hospital
NCT ID NCT04199676
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study compares a glucose tolerance test given right after childbirth to the standard test given 6 weeks later in women with gestational diabetes. Researchers want to see if the early test is accurate and if it helps more women get tested. About 300 women will participate.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Glucose tolerance test (diagnostic test)
- What this could lead to
- If accurate, this could allow women with gestational diabetes to be tested before leaving the hospital, improving follow-up and care.
- What could go wrong
- This is a diagnostic accuracy study, not a treatment trial. The immediate test may not match the gold standard, and results may not change outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2020
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All individual diagnosed with gestational diabetes will be approached following admission to labor and delivery and invited to participate.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Pregnant or recently postpartum (postpartum day 0 or 1) * ≥ 18 years of age * Gestational age ≥34 weeks * A1 or A2 gestational diabetes Exclusion Criteria: * Medical exclusion from completing glucose tolerance testing * Steroid administration within 10 days prior to enrollment * Chronic steroid use
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gestational diabetes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Long Beach Memorial Medical Center/Miller Children's and Women's Hospital
RECRUITINGLong Beach, California, 90806, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a social media platform help manage gestational diabetes?
- Chatbot coach takes aim at diabetes risk after pregnancy
- Can almonds tame overnight blood sugar in pregnancy?
- Wearable sensors in early pregnancy may reveal hidden diabetes risk
- Could a simple blood test predict newborn risks in diabetic pregnancies?
- Wearable sensor may replace the dreaded glucose drink test for gestational diabetes